TT
The startup develops antiviral medicines that utilize a physical mechanism to target and disrupt viruses based on their size and lipid envelope curvature. This approach aims to provide effective treatment options for a wide range of viral infectious diseases, including emerging viral threats.
Singapore, Singapore
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops antiviral medicines that utilize a physical mechanism to target and disrupt viruses based on their size and lipid envelope curvature. This approach aims to provide effective treatment options for a wide range of viral infectious diseases, including emerging viral threats.